The death of 19-year-old Josephine Nasr, a law student in London, has sparked serious concerns regarding the safety of tirzepatide, a GLP-1 weight loss drug. Following her prescription for the medication, Nasr experienced severe side effects that led to her untimely death. This…
Nestle is leveraging the rise of GLP-1 weight-loss drugs to create new products aimed at consumers taking medications like Ozempic and Wegovy. The company is utilizing artificial…
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized orforglipron, making the UK the first country in Europe to approve this GLP-1 tablet for weight manag…
Recent clinical trials indicate that synthetic 5-MeO-DMT, a psychedelic compound derived from the Sonoran Desert toad, may offer significant antidepressant effects for treatment-r…
In a bold new initiative, the administration seeks to reassure investors that while psychedelic research faces hurdles, their bank accounts will float high above any mental health…
Wall Street's main indices experienced gains, led by healthcare stocks hitting record highs and easing oil prices. The Dow Jones rose by 0.97%, while the S&P 500 and Nasdaq also s…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…